{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-061393","form_type":"8-K/A","ticker":"AXGN","cik":"0000805928","company_name":"Axogen, Inc.","filed_at":"2026-09-10T20:55:04+00:00","discovered_at":"2026-09-10T20:56:00.791199+00:00","generated_at":"2026-09-10T20:56:06.986820+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"low","headline":"Axogen files merger agreement with BioCircuit Technologies; terms not disclosed","bullets":["Axogen entered into a merger agreement with BioCircuit Technologies on September 9, 2026, with Omega Merger Sub as merger sub.","Agreement filed as Exhibit 2.1; Michelle Jarrard named representative for BioCircuit equityholders.","Corrected investor presentation dated September 10, 2026 furnished as Exhibit 99.2.","No deal value, premium, or closing conditions disclosed in the filing text."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-061393","json":"https://secwatch.observer/filing/0001628280-26-061393.json","markdown":"https://secwatch.observer/filing/0001628280-26-061393.md","text":"https://secwatch.observer/filing/0001628280-26-061393.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/805928/000162828026061393/0001628280-26-061393-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/805928/000162828026061393/axgn-20260909.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-10T20:56:06.986820+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}